论文部分内容阅读
原发性肝癌(下称肝癌)是我国最常见的恶性肿瘤之一。随着医学技术的进步,肝癌的诊断技术已日趋完善,亚临床期肝癌已可被诊断。早期发现,早期治疗,也给早、中期肝癌病人带来了生机。肝癌的治疗手段很多,手术切除已成为安全、有效的治疗手段,但根治性切除术后的高复发率严重影响肝癌总体外科疗效。肝癌术后的复发目前已成为影响肝癌病人疗效和获得长期生存的关键,也是当前肝癌研究的热点。如何预测肝癌复发转移的发生,及时作出早期诊断;同时寻找更有效的预防肝癌转移复发的方法,是目前临床亟待解决的课题。
Primary liver cancer (hereinafter referred to as liver cancer) is one of the most common malignant tumors in our country. With advances in medical technology, the diagnosis of liver cancer has become increasingly sophisticated, subclinical liver cancer has been diagnosed. Early detection, early treatment, but also to early and mid-term liver cancer patients brought vitality. There are many treatments for liver cancer. Surgical resection has become a safe and effective treatment. However, the high recurrence rate after radical resection has a serious impact on the overall surgical efficacy of liver cancer. Postoperative recurrence of liver cancer has now become the key to affect the efficacy and long-term survival of patients with liver cancer, liver cancer research is also the current hot spot. How to predict the occurrence of recurrence and metastasis of liver cancer, and make early diagnosis in time; At the same time looking for a more effective method to prevent recurrence and metastasis of liver cancer is currently the subject of urgent clinical problems.